Yang CHEN, Lu-Ying GUO, Ling-Fei ZHAO, Yan-Hong MA, Xue-Ling ZHU, Ying XU, Jiang-Hua CHEN. Can sacubitril/valsartan become the promising drug to delay the progression of chronic kidney disease?[J]. Journal of Geriatric Cardiology, 2020, 17(12): 782-786. DOI: 10.11909/j.issn.1671-5411.2020.12.002
|
Citation:
|
Yang CHEN, Lu-Ying GUO, Ling-Fei ZHAO, Yan-Hong MA, Xue-Ling ZHU, Ying XU, Jiang-Hua CHEN. Can sacubitril/valsartan become the promising drug to delay the progression of chronic kidney disease?[J]. Journal of Geriatric Cardiology, 2020, 17(12): 782-786. DOI: 10.11909/j.issn.1671-5411.2020.12.002
|
Yang CHEN, Lu-Ying GUO, Ling-Fei ZHAO, Yan-Hong MA, Xue-Ling ZHU, Ying XU, Jiang-Hua CHEN. Can sacubitril/valsartan become the promising drug to delay the progression of chronic kidney disease?[J]. Journal of Geriatric Cardiology, 2020, 17(12): 782-786. DOI: 10.11909/j.issn.1671-5411.2020.12.002
|
Citation:
|
Yang CHEN, Lu-Ying GUO, Ling-Fei ZHAO, Yan-Hong MA, Xue-Ling ZHU, Ying XU, Jiang-Hua CHEN. Can sacubitril/valsartan become the promising drug to delay the progression of chronic kidney disease?[J]. Journal of Geriatric Cardiology, 2020, 17(12): 782-786. DOI: 10.11909/j.issn.1671-5411.2020.12.002
|
DownLoad: